Nextel Medical Corp. (MAJI) stock: key figures, P/E, revenue and dividend

Communication Services · United States · ISIN US36257K2087

Price
0.00 USD
Market cap
268,082.91 USD
P/E (2026)
–
P/S (2026)
536.17
Dividend yield
0.00 %
Net margin
2,703,644.60 %
Return on equity (ROE)
99.59 %
Return on assets (ROA)
94.13 %

Nextel Medical Corp. financials

Fiscal year2026
Revenue500.00 USD
Gross profit-173,070.00 USD
Operating income-508,734.00 USD
Net income13.52 m USD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Nextel Medical Corp.

Nextel Medical Corp., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Exousia Pro, Inc. and changed its name to Nextel Medical Corp. in April 2026. Nextel Medical Corp. was incorporated in 2010 and is based in Saint Petersburg, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.